Cure EB
Funding rounds backed by Cure EB.
- Funding disclosed in full
- $2.7M
- Median round
- $2.7M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Healome Therapeutics Develops proprietary eye-drop matrix technology for ocular surface diseases | £2MSeed | BiotechUnited Kingdom |